CME Group Inc. (NASDAQ:CME – Get Free Report) COO Suzanne Sprague sold 1,500 shares of CME Group stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the completion of the transaction, the chief operating officer now owns 8,036 shares of the company’s stock, valued at approximately $2,063,885.88. This trade represents a 15.73 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link.
CME Group Price Performance
NASDAQ:CME opened at $254.04 on Friday. CME Group Inc. has a one year low of $190.70 and a one year high of $258.78. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The stock has a market cap of $91.55 billion, a PE ratio of 26.27, a P/E/G ratio of 6.76 and a beta of 0.57. The stock has a 50 day moving average price of $239.65 and a 200 day moving average price of $230.23.
CME Group (NASDAQ:CME – Get Free Report) last posted its earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Equities research analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.
CME Group Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a dividend of $1.25 per share. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a dividend yield of 1.97%. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio (DPR) is currently 51.71%.
Wall Street Analyst Weigh In
Several research analysts have recently commented on the company. Deutsche Bank Aktiengesellschaft reduced their price target on CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. JPMorgan Chase & Co. boosted their price target on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research note on Thursday, February 13th. Barclays upped their target price on CME Group from $257.00 to $263.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 13th. Piper Sandler increased their price target on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 7th. Finally, Keefe, Bruyette & Woods increased their price target on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Four equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $235.50.
View Our Latest Research Report on CME
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently modified their holdings of the company. Meyer Handelman Co. purchased a new position in shares of CME Group during the fourth quarter worth $6,144,000. Spire Wealth Management boosted its holdings in CME Group by 37.4% in the fourth quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock valued at $307,000 after purchasing an additional 359 shares during the period. Lake Street Advisors Group LLC boosted its holdings in CME Group by 108.7% in the fourth quarter. Lake Street Advisors Group LLC now owns 12,390 shares of the financial services provider’s stock valued at $2,949,000 after purchasing an additional 6,453 shares during the period. AEGON ASSET MANAGEMENT UK Plc boosted its holdings in CME Group by 19.3% in the fourth quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock valued at $75,730,000 after purchasing an additional 52,862 shares during the period. Finally, Bank of Montreal Can boosted its holdings in CME Group by 41.8% in the third quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after purchasing an additional 303,169 shares during the period. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Articles
- Five stocks we like better than CME Group
- Top Biotech Stocks: Exploring Innovation Opportunities
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- 3 Stocks to Consider Buying in October
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- How to Effectively Use the MarketBeat Ratings Screener
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.